Search
extranodal marginal zone B-cell lymphoma; low grade B-cell lymphoma of MALT [mucosa associated lymphoid tissue] type, MALToma
Mucosa associated lymphoid tissue (MALT).
Classification:
- working formulation category: small lymphocytic lymphoma
- primary cutaneous marginal cell lymphoma
- associated with Borrelia burdorferi infection in Europe
- gastric marginal zone lymphoma
- associated with Helicobacter pylori
Etiology:
1) gastric MALT lymphoma arises following chronic infection with H pylori
2) may arise in association with autoimmune disease
- Sjogren syndrome
- Hashimoto thyroiditis
- lymphoepithelial sialadenitis
Epidemiology:
1) accounts for 50% of gastric lymphomas
2) 7-8% of B cell lymphomas
3) generally occurs in older patients, median age 61
Pathology:
1) tumors are low-grade
2) dense infiltrates of B lymphocytes of the mucosal lymphoid tissue
2) tumors often remain restricted to mucosa, but may become invasive & life-threatening
Genetics:
- t(11;18)(q21;q21) involving MALT1 & BIRC3 genes
- t(1;14)(p22;q32) involving BCL10 with IgH
- t(1;18) involving API2 [2]
- mutations associated with BCL10
Immunophenotype:
- IgM typically, less often IgA or IgG
- light chain restriction
- CD5 -
- CD11c +/- weak
- CD20 +
- CD21 +, CD35 + (marginal zone cell associated antigens)
- CD23 -
- CD43 +/-
- CD79a +
Clinical manifestations:
- variable presentations
- gastric lymphomas
- isolated bilateral lower palpebral MALT lymphoma described [8]
- unilateral pulmonary [2]
Management:
1) eradication of H pylori (if present) is initial treatment of MALT lymphoma [2]
- may result in regression & even disappearance of MALT lymphomas [2,5,6]
- duration of H pylori treatment 6-8 weeks to months guided by treatment response assessed by repeat upper endoscopy [2]
- only effective for gastric MALT lymphoma [2]
2) surgical resection with involved field radiation therapy for tumors that do not respond to eradication of H pylori [2]
3) chemotherapy as indicated
a) rituximab (Rituxan) anti-CD20 [2,4]
b) alkylating agents
Interactions
disease interactions
General
marginal zone B-cell lymphoma
small lymphocytic lymphoma
References
- Chan JK, Banks PM, Cleary ML, Delsol G, De Wolf-Peeters C,
Falini B, Gatter KC, Grogan TM, Harris NL, Isaacson PG, et al.
A revised European-American classification of lymphoid
neoplasms proposed by the International Lymphoma Study Group.
A summary version.
Am J Clin Pathol. 1995 May;103(5):543-60.
PMID: 7741099
- Medical Knowledge Self Assessment Program (MKSAP) 11, 15, 16,17, 18, 19.
College of Physicians, Philadelphia 1998, 2009, 2012, 2015, 2018, 2021.
- WHO Classification Tumours of Haematopoietic and Lymphoid
Tissues. IARC Press 2001.
- Ferreri AJ, Zucca E.
Marginal-zone lymphoma.
Crit Rev Oncol Hematol. 2007 Sep;63(3):245-56.
Epub 2007 Jun 20. Review.
PMID: 17583528
- Stathis A et al.
Long-term outcome following Helicobacter pylori eradication
in a retrospective study of 105 patients with localized
gastric marginal zone B-cell lymphoma of MALT type.
Ann Oncol 2009 Jun; 20:1086.
PMID: 19193705
- Stathis A, Bertoni F, Zucca E.
Treatment of gastric marginal zone lymphoma of MALT type.
Expert Opin Pharmacother. 2010 Sep;11(13):2141-52
PMID: 20586708
- Zucca E, Bertoni F, Roggero E, Cavalli F.
The gastric marginal zone B-cell lymphoma of MALT type.
Blood. 2000 Jul 15;96(2):410-9.
PMID: 10887100
- Lalya I, Mansouri H
Bilateral Lower Palpebral MALT Lymphoma
N Engl J Med 2015; 372:363. January 22, 2015
PMID: 25607429
http://www.nejm.org/doi/full/10.1056/NEJMicm1400091
- Zucca E, Bertoni F.
The spectrum of MALT lymphoma at different sites: biological
and therapeutic relevance.
Blood. 2016 Apr 28;127(17):2082-92. Review.
PMID: 26989205 Free Article
- Wenzel J et al,
The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous
T-cell lymphoma and pityriasis lichenoides
J Am Acad Dermatol 2005; 53:422
PMID: 16112347
- Rossi D, Bertoni F, Zucca E.
Marginal-Zone Lymphomas.
N Engl J Med 2022; 386:568-581
PMID: 35139275
https://www.nejm.org/doi/full/10.1056/NEJMra2102568